Which test is superior for diagnosing pheochromocytoma: plasma free metanephrines or 24‑hour urinary fractionated metanephrines?

Plasma Free Metanephrines Are Superior to 24-Hour Urinary Fractionated Metanephrines for Diagnosing Pheochromocytoma

Plasma free metanephrines measured by liquid chromatography with mass spectrometry (LC-MS/MS) or electrochemical detection (LC-ECD) should be your first-line test for diagnosing pheochromocytoma, with blood drawn after the patient has been supine for at least 30 minutes. This test offers the highest combined sensitivity (96-99%) and specificity (89-90%) for detecting these potentially lethal tumors 1, 2.

Why Plasma Metanephrines Win

The 2014 Endocrine Society Clinical Practice Guideline establishes that plasma free metanephrines demonstrate superior diagnostic performance compared to urinary testing 1. When comparing the two tests head-to-head across five major studies, plasma metanephrines consistently showed:

• Higher specificity: 89-98% for plasma vs. 69-86% for urine 1
• Comparable sensitivity: Both tests achieve 90-99% sensitivity 1
• Better performance for small tumors: Plasma testing maintains 95% sensitivity even for tumors ≤3 cm, while urinary testing sensitivity drops significantly 3, 4

The landmark NIH study with over 800 patients demonstrated that plasma metanephrines outperformed all other biochemical tests, including combinations of multiple tests 1, 2.

Critical Sampling Requirements

The superiority of plasma testing depends entirely on proper collection technique 1:

• Patient must be fully recumbent for at least 30 minutes before blood draw
• Use reference intervals established for supine position
• If blood is drawn seated, expect increased false-positives requiring repeat supine sampling

The guideline explicitly states that when proper supine sampling cannot be performed, urinary fractionated metanephrines become the preferred alternative 1.

When Urinary Testing Makes Sense

Use 24-hour urinary fractionated metanephrines when 1:

• Phlebotomy staff cannot accommodate 30-minute supine positioning
• Patient cannot tolerate prolonged supine position
• Initial plasma results are borderline elevated (use urine as confirmatory test)
• You need to verify completeness of collection (measure urinary creatinine) 1

The Measurement Method Matters Enormously

Only use LC-MS/MS or LC-ECD methods—avoid immunoassays 1. Immunoassays substantially underestimate metanephrine concentrations and show lower diagnostic sensitivity compared to chromatography-based methods. Quality assurance programs confirm that immunoassays suffer from both imprecision and systematic underestimation 1.

Handling Borderline Results

Approximately 25% of patients with pheochromocytoma present with borderline elevations 1. When plasma results are mildly elevated:

1. First, repeat plasma sampling in proper supine position (most common cause of borderline positives is improper sampling) 1
2. If still elevated, consider clonidine suppression test (97% sensitivity, 100% specificity—though not prospectively validated) 1
3. Alternatively, add urinary fractionated metanephrines as confirmatory test 1
4. For low pretest probability with persistent mild elevation, adopt wait-and-retest approach at 6+ months 1

Common Pitfalls to Avoid

Medications and physiological stress cause false-positives 1:

• Tricyclic antidepressants interfere with catecholamine disposition
• Acetaminophen, mesalamine, sulfasalazine interfere with LC-ECD methods
• Extreme illness in ICU settings causes marked elevations
• Always consider confirmatory testing after excluding these factors

For plasma testing including 3-methoxytyramine measurement, require overnight fasting 1.

Recent Evidence Confirms the Hierarchy

The most recent 2023 Russian study of 1,088 adrenal neoplasms found plasma free fractionated metanephrines achieved 95.4% sensitivity without decreased performance in small tumors, while unfractionated urinary metanephrines showed only 67.6% sensitivity despite 97.8% specificity 3. A 2024 Turkish study confirmed plasma and urine tests can be used interchangeably, with urinary fractionated metanephrine showing 90% sensitivity vs. 84% for plasma, though plasma normetanephrine was most specific at 91.4% 5.

The 2026 Japanese multicenter study revealed that current enzyme immunoassay cutoffs show limited sensitivity (82.2%), particularly for paragangliomas (76%) 6. This reinforces the guideline recommendation to use LC-MS/MS or LC-ECD methods rather than immunoassays.

Bottom Line Algorithm

1. First-line: Plasma free metanephrines by LC-MS/MS or LC-ECD, drawn after 30 minutes supine 1, 2
2. If proper supine sampling impossible: 24-hour urinary fractionated metanephrines with creatinine verification 1
3. If borderline positive: Repeat supine plasma or add urinary testing as confirmation 1
4. Never use: Immunoassay methods or seated plasma samples without plan for supine confirmation 1

This approach prioritizes avoiding missed diagnoses of potentially fatal tumors while maintaining acceptable specificity to minimize unnecessary imaging and interventions 1.